Description:
WellSIM Biomedical Technologies, Inc. is a liquid biopsy biotechnology company developing and commercializing complete diagnostic solutions for non-invasive cancer testing through the precise stabilization, enrichment, isolation, and analytical interrogation of circulating extracellular vesicles and exosomes from cell-free specimens such as urine, saliva, and plasma.